Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Cornely, OA; Ullmann, AJ; Karthaus, M

Comment on: Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies

J Antimicrob Chemother. Bd. 57. H. 1. 2006 S. 151-2; author reply 152-4


Buhl, R; Vinkler, I; Magyar, P et al.

Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma.

Pulm Pharmacol Ther. Bd. 19. H. 6. 2006 S. 404-12




Hartwig, UF; Nonn, M; Khan, S et al.

Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.

Bone Marrow Transpl. Bd. 37. H. 3. 2006 S. 297-305


Rucker, FG; Bullinger, L; Schwaenen, C et al.

Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.

J Clin Oncol. Bd. 24. H. 24. 2006 S. 3887-94


Schimanski, CC; Bahre, R; Gockel, I et al.

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.

Br J Cancer. Bd. 95. H. 2. 2006 S. 210-7


Lopez-Kostka, S; Knop, J; Konur, A et al.

Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections.

J Invest Dermatol. Bd. 126. H. 7. 2006 S. 1582-9


Jansen, JP; Kern, WV; Cornely, OA et al.

Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany.

Value Health. Bd. 9. H. 1. 2006 S. 12-23


Hess, G; Flohr, T; Kolbe, K et al.

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma.

Ann Hematol. Bd. 85. H. 11. 2006 S. 769-79